Source: MarTech Series.
  • ImagineAR (IP) has partnered with SIDEARM Sports to deliver immersive college football augmented reality (AR) experiences this January
  • SIDEARM Sports is a digital provider for college athletics and has over 1,500 partners
  • ImagineAR is a self-publishing AR platform that enables businesses of any size to create and implement their own digital campaigns
  • The AR platform works with IOS and Android mobile devices and wearable technologies
  • ImagineAR Inc. (IP) is unchanged trading at $0.04 per share

ImagineAR (IP) has partnered with SIDEARM Sports to deliver college football AR experiences.

SIDEARM Sports is a digital provider for college athletics based in Syracuse, New York. It offers software and technology that powers websites, mobile applications, CTV, live stats, and video streaming for over 1,500 partners.

Alen Paul Silverrstieen, CEO of ImagineAR, stated,

“College sports has always been one of our target markets where AR is understood and expected to be very successful… SIDEARM is the leader in college sports mobile apps and ImagineAR is excited to execute our first SDK agreement with them.”

ImagineAR is a self-publishing augmented reality platform that enables businesses of any size to create and implement their own digital campaigns with no programming or technology experience.

Customers can point their mobile device at logos, signs, buildings, products, landmarks and more for any interactive content all hosted in the cloud and managed using a menu-driven portal. The company’s AR platform works with IOS and Android mobile devices and upcoming wearable technologies.

ImagineAR Inc. (IP) is unchanged trading at $0.04 per share as of 12:51 pm ET.


More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.